CAS: 1610516-67-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ML318 REF: AN-AG01V74ACAS: 1610516-67-0 | 98% | 183.00 €~578.00 € | Thu 11 Jul 24 |
 | ML318 REF: TM-T8533CAS: 1610516-67-0 | 98.65% | 55.00 €~877.00 € | Thu 18 Jul 24 |
 | ML318 REF: 3D-KPC51667CAS: 1610516-67-0 | Min. 95% | To inquire | Thu 22 Aug 24 |
Ref: AN-AG01V74A
| 10mg | 183.00 € | ||
| 25mg | 482.00 € | ||
| 50mg | 578.00 € |
Estimated delivery in United States, on Thursday 11 Jul 2024
ML318
CAS:1610516-67-0
ML318 is a biaryl nitrile PvdQ acylase inhibitor (IC50 of 20 nM for binding in …
Formula:
C14H8F4N2
Purity:
98.65%
Color and Shape:
Solid
Molecular weight:
280.22
Ref: TM-T8533
| 1mg | 55.00 € | ||
| 2mg | 80.00 € | ||
| 5mg | 118.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 416.00 € | ||
| 50mg | 611.00 € | ||
| 100mg | 877.00 € | ||
| 1ml*10 (DMSO) | 128.00 € |
Estimated delivery in United States, on Thursday 18 Jul 2024
ML318
CAS:1610516-67-0
ML318 is an analog inhibitor that has shown promising results in the treatment of cancer. …
Formula:
C14H8F4N2
Purity:
Min. 95%
Molecular weight:
280.22 g/mol
Ref: 3D-KPC51667
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 22 Aug 2024
